Literature DB >> 28627410

Current and upcoming mitochondrial targets for cancer therapy.

Hyoung Kyu Kim1, Yeon Hee Noh2, Bernd Nilius3, Kyung Soo Ko2, Byoung Doo Rhee2, Nari Kim2, Jin Han4.   

Abstract

Mitochondria are essential intracellular organelles that regulate energy metabolism, cell death, and signaling pathways that are important for cell proliferation and differentiation. Therefore, mitochondria are fundamentally implicated in cancer biology, including initiation, growth, metastasis, relapse, and acquired drug resistance. Based on these implications, mitochondria have been proposed as a major therapeutic target for cancer treatment. In addition to classical view of mitochondria in cancer biology, recent studies found novel pathophysiological roles of mitochondria in cancer. In this review, we introduce recent concepts of mitochondrial roles in cancer biology including mitochondrial DNA mutation and epigenetic modulation, energy metabolism reprogramming, mitochondrial channels, involvement in metastasis and drug resistance, and cancer stem cells. We also discuss the role of mitochondria in emerging cancer therapeutic strategies, especially cancer immunotherapy and CRISPR-Cas9 system gene therapy.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas9; Cancer immunotherapy; Cancer stem cell; Mitochondria; Mitochondria channels

Mesh:

Substances:

Year:  2017        PMID: 28627410     DOI: 10.1016/j.semcancer.2017.06.006

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  16 in total

1.  2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells.

Authors:  Magdalena Gorska-Ponikowska; Alicja Kuban-Jankowska; Stephan A Eisler; Ugo Perricone; Giosuè Lo Bosco; Giampaolo Barone; Stephan Nussberger
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

2.  Multiomic Profiling of Tyrosine Kinase Inhibitor-Resistant K562 Cells Suggests Metabolic Reprogramming To Promote Cell Survival.

Authors:  Brett M Noel; Steven B Ouellette; Laura Marholz; Deborah Dickey; Connor Navis; Tzu-Yi Yang; Vinh Nguyen; Sarah J Parker; David Bernlohr; Zohar Sachs; Laurie L Parker
Journal:  J Proteome Res       Date:  2019-02-21       Impact factor: 4.466

Review 3.  Therapeutic approach for digestive system cancers and potential implications of exercise under hypoxia condition: what little is known? a narrative review.

Authors:  Sergio Pérez Regalado; Josefa León; Belén Feriche
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-14       Impact factor: 4.322

4.  Mechanistic investigations of antitumor activity of a Rhodamine B‑oleanolic acid derivative bioconjugate.

Authors:  Ioana Macașoi; Ioana Zinuca Pavel; Alina Elena Moacă; Ștefana Avram; Vlad Laurențiu David; Dorina Coricovac; Alexandra Mioc; Demetrios A Spandidos; Aristidis Tsatsakis; Codruța Șoica; Victor Dumitrașcu; Cristina Dehelean
Journal:  Oncol Rep       Date:  2020-06-26       Impact factor: 3.906

Review 5.  Multifaceted Roles of Mitochondrial Components and Metabolites in Metabolic Diseases and Cancer.

Authors:  Jean Nakhle; Anne-Marie Rodriguez; Marie-Luce Vignais
Journal:  Int J Mol Sci       Date:  2020-06-20       Impact factor: 5.923

6.  Loss of PKM2 in Lgr5+ intestinal stem cells promotes colitis-associated colorectal cancer.

Authors:  Yeji Kim; Yong-Soo Lee; Sung Wan Kang; Seungil Kim; Tae-Young Kim; Su-Hyun Lee; Sung Wook Hwang; Jihun Kim; Eun Na Kim; Jin-Sung Ju; Yun-Yong Park; Mi-Na Kweon
Journal:  Sci Rep       Date:  2019-04-17       Impact factor: 4.379

7.  TPP-related mitochondrial targeting copper (II) complex induces p53-dependent apoptosis in hepatoma cells through ROS-mediated activation of Drp1.

Authors:  Jiangjuan Shao; Mengmeng Li; Zijian Guo; Chun Jin; Feng Zhang; Chunyan Ou; Yaochen Xie; Shanzhong Tan; Zhenyi Wang; Shizhong Zheng; Xiaoyong Wang
Journal:  Cell Commun Signal       Date:  2019-11-19       Impact factor: 5.712

8.  Mitochondria-acting carrier-free nanoplatform self-assembled by α-tocopheryl succinate carrying cisplatin for combinational tumor therapy.

Authors:  Heng Mei; Jing Li; Shengsheng Cai; Xuequan Zhang; Wenqiang Shi; Hai Zhu; Jun Cao; Bin He
Journal:  Regen Biomater       Date:  2021-06-30

Review 9.  Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.

Authors:  Angelica Avagliano; Giuseppina Granato; Maria Rosaria Ruocco; Veronica Romano; Immacolata Belviso; Antonia Carfora; Stefania Montagnani; Alessandro Arcucci
Journal:  Biomed Res Int       Date:  2018-06-05       Impact factor: 3.411

10.  Sericin nanomicelles with enhanced cellular uptake and pH-triggered release of doxorubicin reverse cancer drug resistance.

Authors:  Weihong Guo; Lizhi Deng; Jiang Yu; Zhaoyu Chen; Yanghee Woo; Hao Liu; Tuanjie Li; Tian Lin; Hao Chen; Mingli Zhao; Liming Zhang; Guoxin Li; Yanfeng Hu
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.